Home / Sweden / SynAct Pharma AB
SynAct Pharma AB
SE0008241491 Short position disclosed on July 15, 2026.
0.79% of the capital sold short
1 disclosing funds
18 disclosures on record
Evolution of the disclosed total
Open positions
| Fund | % of capital | Since |
|---|---|---|
| Citadel Securities (Europe) Limited | 0.79% | July 15, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 15, 2026 | Citadel Securities (Europe) Limited | 0.79% | still open |
| July 10, 2026 | Citadel Securities (Europe) Limited | 0.80% | still open |
| July 7, 2026 | Citadel Securities (Europe) Limited | 0.79% | still open |
| July 3, 2026 | Citadel Securities (Europe) Limited | 0.80% | still open |
| June 30, 2026 | Citadel Securities (Europe) Limited | 0.79% | still open |
| June 29, 2026 | Citadel Securities (Europe) Limited | 0.69% | still open |
| June 26, 2026 | Citadel Securities (Europe) Limited | 0.59% | still open |
| June 24, 2026 | Citadel Securities (Europe) Limited | 0.64% | still open |
| June 22, 2026 | Citadel Securities (Europe) Limited | 0.50% | still open |
| June 16, 2026 | Citadel Securities (Europe) Limited | 0.52% | still open |
| November 22, 2023 | Citadel Securities (Europe) Limited | 0.51% | still open |
| November 7, 2023 | Citadel Securities (Europe) Limited | 0.54% | still open |
| November 3, 2023 | Millennium International Management LP | 0.51% | still open |
| November 2, 2023 | Citadel Securities (Europe) Limited | 0.52% | still open |
| November 1, 2023 | Citadel Securities (Europe) Limited | 0.80% | still open |
| October 17, 2023 | Millennium International Management LP | 0.52% | still open |
| October 4, 2023 | Citadel Securities (Europe) Limited | 0.50% | still open |
| September 12, 2023 | Citadel Securities (Europe) Limited | 0.50% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.32% of the capital sold short
- Elekta AB (publ) 10.26% of the capital sold short
- JM AB 7.01% of the capital sold short
- Embracer Group AB 6.06% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.61% of the capital sold short
- Hemnet Group AB (publ) 5.59% of the capital sold short
- Bonesupport Holding AB 5.38% of the capital sold short
- Truecaller AB 5.38% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Aktiebolaget Electrolux 4.12% of the capital sold short
- Stillfront Group AB (publ) 3.96% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short